CM
CABA icon

Caption Management’s Cabaletta Bio CABA Stock Holding History

Caption Management’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-425,000
Closed -$7.25M – 1183
2024
Q1 		$7.25M Buy
425,000
+325,000
+325% +$6.98M 0.11% 232
2023
Q4 		$2.27M Buy
+100,000
New +$1.68M 0.03% 576

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Caption Management's CABA Position: Q3 2024 in Review

Caption Management sold out of Cabaletta Bio (CABA) in Q3 2024, closing a stake of 3,889 shares — an estimated $29.1K sold.

Caption Management first reported a position in CABA in Q4 2021 and held it in 5 quarters. The position peaked at $2.73M in Q1 2024. 120 funds tracked by Wall St. Rank hold CABA as of Q3 2024.

  • Caption Management reported no remaining Cabaletta Bio position as of Q3 2024 after selling out during the quarter.
  • Caption Management sold 3,889 Cabaletta Bio shares in Q3 2024, an estimated $29.1K.
  • Caption Management first reported a position in Cabaletta Bio in Q4 2021 and held it in 5 quarters.
  • Caption Management's Cabaletta Bio position peaked at $2.73M in Q1 2024.
  • 120 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2024.

Based on Caption Management's 13F filing for Q3 2024, filed 14 Nov 2024.